Wuhan Huakang Century Medical Co., Ltd
Initial public offering and listing on GEM
Announcement on online subscription and winning rate
Sponsor (lead underwriter):
The application of Wuhan Huakang Century Medical Co., Ltd. for the initial public offering of 26.4 million RMB common shares (A shares) (hereinafter referred to as "this offering") was examined and approved by the GEM Listing Committee of Shenzhen Stock Exchange on November 5, 2021, and approved to register by the CSRC's CSRC permit [2021] No. 4121 on December 28, 2021.
The issuer negotiated with the sponsor (lead underwriter) Huaying Securities Co., Ltd. (hereinafter referred to as "Huaying securities" or "sponsor (lead underwriter)") to determine the number of shares to be issued this time is 26.4 million shares, and the issue price is 39.30 yuan / share.
This offering is conducted by a combination of directional placement to strategic investors (hereinafter referred to as "strategic placement"), offline inquiry placement to qualified investors (hereinafter referred to as "offline issuance") and online pricing issuance to social public investors holding the market value of non restricted A-Shares and non restricted depositary receipts in Shenzhen market (hereinafter referred to as "online issuance").
The issuing price of this offering exceeds the median and weighted average of offline investors' quotation after excluding the highest quotation, as well as the securities investment fund, national social security fund, basic old-age insurance fund established through public offering after excluding the highest quotation The enterprise annuity fund established in accordance with the measures for the administration of enterprise annuity fund and the insurance fund quotation median and weighted average in accordance with the measures for the administration of the use of insurance funds, etc., whichever is lower, so the relevant subsidiaries of the sponsor shall participate in the follow-up investment.
According to the issuance price of 39.30 yuan / share determined through negotiation between the issuer and the sponsor (lead underwriter), the scale of this issuance is 1037.52 million yuan. According to the detailed rules for the implementation of securities issuance and underwriting business of gem initial public offering of Shenzhen Stock Exchange (revised in 2021), "for those with an issuance scale of more than 1 billion yuan and less than 2 billion yuan, the follow-up investment proportion is 4%, but not more than 60 million yuan", Wuxi Guolian Innovation Investment Co., Ltd., a subsidiary of the parent company Guolian Securities Co.Ltd(601456) of Huaying Securities Co., Ltd., the sponsor of the issuance, finally placed 1056000 shares, accounting for 4.00% of the issuance.
According to the finally determined price, the final strategic placement quantity of the special asset management plan for senior managers and core employees of the issuer (i.e. Guolian Huakang medical employees participating in the gem strategic placement collective asset management plan, hereinafter referred to as "Huakang medical special asset management plan") is 788804 shares, and the difference from the initial expected subscription quantity will be transferred back to offline issuance.
The number of shares issued by the initial strategic placement of this offering was 3.96 million shares, accounting for 15.00% of the number of shares issued. According to the issuance price of this issuance, the final number of strategic placement shares in the special asset management plan for senior managers and core employees of the issuer is 788804 shares, accounting for about 2.99% of the number of shares issued this time; The final number of strategic placement shares of relevant subsidiaries of the sponsor was 1056000 shares, accounting for 4% of the number of shares issued this time. The difference between the initial strategic placement and the final strategic placement was 2115196 shares, which were transferred back to offline issuance. After the strategic placement callback and before the online and offline callback mechanism was launched, the initial offline issuance was 1782319600 shares, accounting for 72.58% of the issuance after deducting the final strategic placement; The initial number of shares issued online was 6.732 million, accounting for 27.42% of the number issued after deducting the final strategic placement. The total number of final offline and online issuance is 245551960 shares, and the final number of online and offline issuance will be determined according to the call back situation.
On January 19, 2022 (t day), Huakang medical issued 6.732 million shares of "Huakang medical" through the online pricing of the trading system of Shenzhen Stock Exchange.
Investors are kindly requested to focus on the issuance process, online and offline subscription and payment, disposal of share abandonment, etc., and timely fulfill their payment obligations on January 21, 2022 (T + 2).
1. Offline investors shall, in accordance with the announcement of initial public offering and initial placement results of offline issuance of Wuhan Huakang Century Medical Co., Ltd. listed on the gem, timely and fully pay the subscription funds for new shares according to the finally determined issuance price and allocated quantity before 16:00 on January 21 (T + 2) 2022. The subscription funds shall be paid in full within the specified time. If the subscription funds are not paid in full within the specified time or as required, all the new shares allocated to the placing object shall be invalid. If the above circumstances occur when multiple new shares are issued on the same day, all the placing objects are invalid. If different placing objects share bank accounts, if the subscription funds are insufficient, the new shares allocated to the placing objects sharing bank accounts will be invalid. Offline investors are allocated multiple new shares on the same day. Please pay for each new share separately.
After the online investors win the lot in the subscription of new shares, they shall fulfill the obligation of capital settlement in accordance with the announcement on the results of initial public offering and online lottery of Wuhan Huakang Century Medical Co., Ltd. listed on the gem, so as to ensure that their capital account will eventually have sufficient capital for the subscription of new shares on January 21 (T + 2) 2022, and the insufficient part shall be deemed to have given up the subscription, The resulting consequences and relevant legal liabilities shall be borne by the investors themselves. The investor's fund transfer shall comply with the relevant provisions of the securities company where the investor is located.
The shares that offline and online investors give up to subscribe for shall be underwritten by the sponsor (lead underwriter).
2. Among the shares issued this time, the shares issued online have no circulation restrictions and restricted sales period arrangements, and can be circulated from the date of listing of the shares issued this time on the Shenzhen Stock Exchange.
The offline issuance part adopts the proportional sales restriction method, and the offline investors shall promise 10% of the number of shares allocated to them. If less than 1 share is rounded up, the sales restriction period is 6 months from the date of the issuer's initial public offering and listing. That is, among the shares allocated to each placing object, 90% of the shares are sold indefinitely and can be circulated from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange; The sales restriction period of 10% of the shares is 6 months, which shall be calculated from the date of listing and trading of the issued shares on the Shenzhen Stock Exchange.
When offline investors participate in the preliminary inquiry and quotation and offline subscription, they do not need to fill in the arrangement of the sales restriction period for the placing objects under their management. Once the quotation is made, it is deemed to accept the arrangement of the online sales restriction period disclosed in this announcement.
In terms of strategic placement, the senior management and core employees of the issuer participate in the special asset management plan established by the strategic placement, and the restricted period of shares allocated is 12 months, which shall be calculated from the date of listing of the shares publicly issued on the Shenzhen Stock Exchange; The restricted sale period of the shares allocated to the relevant subsidiaries of the recommendation institution is 24 months, and the restricted sale period shall be calculated from the date when the shares of this public offering are listed on the Shenzhen Stock Exchange.
After the expiration of the sales restriction period, the reduction of the allocated shares by the strategic investors shall be subject to the relevant provisions of the CSRC and the Shenzhen Stock Exchange on share reduction. 3. When the total number of shares subscribed by offline and online investors is less than 70% of the number of public offerings, the issuer and the sponsor (lead underwriter) will suspend the issuance of new shares and disclose the reasons for the suspension and subsequent arrangements.
4. If the offline investors who provide effective quotation fail to participate in the subscription or the offline investors who obtain the preliminary placement fail to pay the subscription amount in time and in full, it will be deemed as a breach of contract and shall bear the liability for breach of contract. The recommendation institution (lead underwriter) shall report the breach of contract to the China Securities Association for the record. The number of violations of the placing object in the scientific and technological innovation board, gem, motherboard and other sectors shall be calculated together. During the period of being included in the restricted list, the placing object shall not participate in the offline inquiry and placement of projects related to science and innovation board, gem, motherboard and other sectors.
If the online investor fails to make full payment after winning the lottery for 3 times in a row within 12 months, it shall not participate in the online subscription of new shares, depositary receipts, convertible corporate bonds and exchangeable corporate bonds within 6 months (calculated as 180 natural days, including the next day) from the next day of the settlement participant's latest declaration of abandonment of subscription. 1、 Online subscription
According to the data provided by Shenzhen Stock Exchange, the sponsor (lead underwriter) has made statistics on the subscription of this online pricing offering. The results are as follows: the number of effective subscription households of this online pricing offering is 12484467, the number of effective subscription shares is 67599355500, the total number of allotment numbers is 135198711, and the starting number of allotment number is 00000000000 1, The cut-off number is 000135198711.
2、 Implementation of callback mechanism, issuance structure and success rate of online issuance
According to the callback mechanism announced in the announcement of Wuhan Huakang Century Medical Co., Ltd. on initial public offering and listing on the gem, the issuer and the sponsor (lead underwriter) decided to start the callback mechanism because the initial effective online subscription multiple was 10041.49666 times, higher than 100 times, 20% (rounded up to an integral multiple of 500 shares, i.e. 4.9115 million shares) of the number of shares publicly issued this time will be transferred back from offline to online. After the call back, the final number of offline shares issued was 12.911696 million, accounting for 52.58% of the total issued after deducting the final strategic placement; The final number of shares issued online was 11.6435 million, accounting for 47.42% of the total issued after deducting the final strategic placement. After the call back, the winning rate of this online pricing issuance is 0.0172242766%, and the subscription multiple is 5805.75905 times.
3、 Online lottery
The issuer and the recommendation institution (lead underwriter) are scheduled to conduct lottery at Room 308, Shenye center, No. 5045, Shennan East Road, Luohu District, Shenzhen on the morning of January 20 (T + 1), 2022. The lottery will be conducted on cninfo.com.cn on January 21 (T + 2), 2022 China Securities Network (website: www.cs. Com. CN.) China Securities Network (website: www.cn. Stock. Com) Securities Times (website: www.stcn. Com.) Securities Daily (website: www.zqrb. CN) Publish the lottery results on the website.
Issuer: Wuhan Huakang Century Medical Co., Ltd. sponsor (lead underwriter): Huaying Securities Co., Ltd. January 20, 2022 (there is no text on this page (seal page of Wuhan Huakang Century Medical Co., Ltd. for initial public offering and listing on GEM, online subscription and winning rate announcement)
Issuer: Wuhan Huakang Century Medical Co., Ltd. (there is no text on this page, which is the seal page of (announcement of online subscription and winning rate of Wuhan Huakang Century Medical Co., Ltd. for its initial public offering and listing on the GEM)
Sponsor (lead underwriter): Huaying Securities Co., Ltd. mm / DD / yyyy
